Results 1 - 5 of 7 for: "Aralast"
Refine your search:

Aralast NP
Aralast NP is used for: Treating emphysema caused by alpha1-proteinase (A1-P) deficiency (also known as alpha1-antitrypsin deficiency).
Consumer Information (MedFacts) · More like this · Add to my drug list

Aralast
Alpha 1-proteinase inhibitor is a protein, also called alpha 1-antitrypsin. This protein occurs naturally in the body and is important for preventing the breakdown of tissues in the lungs. In people who lack the alpha 1-antitrypsin protein, breakdown of lung tissues can lead to emphysema (damage to...
Consumer Information (Cerner Multum) · More like this · Add to my drug list · En Espanol

Alpha1-Proteinase Inhibitor (Human)
Alpha-1 Proteinase Inhibitor (Human) Pronunciation: (AL-fa 1 PROE-teen-ase) Class: Respiratory enzyme Trade Names: Aralast NP - Injection, lyophilized powder for solution 400mg (greater than or equal to 16 mg/mL of alpha-1 proteinase inhibitor when reconstituted) -...
A-Z Drug Facts (Facts & Comparisons) · More like this · Add to my drug list

Baxter launches Aralast for hereditary emphysema patients needing new therapy
Baxter launches Aralast for hereditary emphysema patients needing new therapy DEERFIELD, Ill., May 30, 2003 -- Baxter announced the launch of Aralast, a new alpha-1 antitrypsin...
News & Articles (Drugs.com) · More like this

Baxter Receives Approval to Process Aralast NP
DEERFIELD, Ill., May 09, 2007 /PRNewswire-FirstCall/ -- Baxter received Food and Drug Administration approval to transfer Aralast processing from a third party to Baxter. Aralast NP is a brand name referring to the therapy completely processed by Baxter. It is biologically...
New Drug Approvals (FDA) · More like this

See also: Alpha-1 Proteinase Inhibitor Deficiency

Having trouble finding what you want?


MedNotes
Advertisement

(web3)